97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,527 / 薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04312113 (ClinicalTrials.gov)	November 16, 2020	14/3/2020	Angiographic Delivery of AD-MSC for Ulcerative Colitis	A Phase I Single Site Open Label Study of Intra-arterial Delivery of Mesenchymal Stem Cells for Luminal Ulcerative Colitis	Ulcerative Colitis	Drug: Adipose derived, autologous mesenchymal stem cells	Mayo Clinic	NULL	Recruiting	18 Years	65 Years	All	20	Phase 1	United States
2	NCT03609905 (ClinicalTrials.gov)	July 1, 2018	1/6/2018	Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis	A Phase I/II Randomized, Controlled, Clinical Trial for Assessment of the Safety and Efficacy of Allogeneic Adipose Mesenchymal Stem Cells in Moderate to Severe Ulcerative Colitis Patients	Ulcerative Colitis (UC)	Biological: Adipose-cord mesenchymal stromal cells (A-MSCs);Other: Conventional drugs	Liaocheng People's Hospital	NULL	Recruiting	18 Years	65 Years	All	50	Phase 1/Phase 2	China
3	EUCTR2017-003524-75-NL (EUCTR)	27/03/2018	19/02/2018	Mesenchymal Stromal Cells for the treatment of Ulcerative Colitis	Allogeneic Bone Marrow Derived Mesenchymal Stromal Cells for the Treatment of Refractory Proctitis in Ulcerative Colitis - BMMSCproctitis	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Product Name: Mesenchymal stromal cells Product Code: MSC INN or Proposed INN: n.a. Other descriptive name: MESENCHYMAL CELLS	Leiden University Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	14	Phase 2	Netherlands